参考文献:(上下滑动查看更多)
[1]母义明,纪立农,杨文英等.中国2型糖尿病患者餐后高血糖管理专家共识[J].中国糖尿病杂志,2016,24(5):385-392.
[2]中华医学会糖尿病学分会,国家基层糖尿病防治管理办公室.国家基层糖尿病防治管理指南(2022)[J].中华内科杂志, 2022, 61(7):32.DOI:10.3760/cma.j.cn112138-20220120-000063.
[3]张俊清, 等. 不同糖耐量人群胰岛素抵抗和胰岛β细胞功能减退的差异. 中国糖尿病杂志 2008,16(2):68-71
[4]Peng W, et al. Lancet Reg Health West Pac. 2024, 43:100809
[5]Wang X, et al. Diabetes Res Clin Pract. 2020 Jan;159:107951.
[6]Lu CX, et al. Clin Ther. 2021 Oct;43(10):1768-1788
[7]Xie C, et al. Diabetes Res Clin Pract. 2021 Jan;171:108610
[8]母义明.利司那肽:一种独特的短效胰高糖素样肽-1受体激动剂[J].药品评价, 2017, 14(15):6.DOI:10.3969/j.issn.1672-2809.2017.15.002.
[9]Werner U. Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptying--preclinical evidence. J Diabetes Complications. 2014 Jan-Feb;28(1):110-4. doi: 10.1016/j.jdiacomp.2013.06.003. Epub 2013 Aug 28. PMID: 23992745.
[10]De Fano M, et al. Diabetes Res Clin Pract. 2023 Sep;203:110828.
[11]Jalleh RJ. Diabetologia. 2022 Dec;65(12):1981-1993.
[12]王徐溢, 吴同智, 孙子林. 从胃排空调节及其影响药物谈2型糖尿病餐后血糖管理策略 [J] . 中华糖尿病杂志, 2017, 09(5) : 334-336. DOI: 10.3760/cma.j.issn.1674-5809.2017.05.014.
[13]Meier JJ, et al. Diabetes Care. 2015 Jul;38(7):1263-73
[14]Kapitza C, Forst T, Coester HV, et al. Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin[J]. Diabetes Obes Metab. 2013 Jul;15(7):642-9.5.
[15]Rosenstock J, Raccah D, Korányi L,et al. Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X)[J].Diabetes Care. 2013 Oct;36(10):2945-51.
[16]https://dom-pubs.onlinelibrary.wiley.com/doi/pdf/10.1111/dom.15857
[17]Liu M, Gu W, Chen L, et al. The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli-D randomized controlled trial. Diabetes Obes Metab. 2024 Sep;26(9):3791-3800. doi: 10.1111/dom.15724. Epub 2024 Jun 22. PMID: 38922731.